Status:
NOT_YET_RECRUITING
Stanford-Lucidify EEG Delirium Study
Lead Sponsor:
Stanford University
Conditions:
Delirium
Cognitive Dysfunction
Eligibility:
All Genders
55+ years
Brief Summary
The purpose of this study is to evaluate the effectiveness of the CGX/Lucidify EEG system in enabling physicians to detect delirium (confusion) in medically ill patients as early as possible in order ...
Detailed Description
Study investigators would like to use a portable electroencephalogram (pEEG), the CGX EEG system (a Research-grade 2-Channel EEG device) to measure the brainwaves of patients admitted to Stanford Medi...
Eligibility Criteria
Inclusion
- Age is 55 years or older
- Clinical suspicion of delirium or subject at risk for delirium
- Admitted to the Intensive Care Unit (ICU) or Oncology wards
- Expected hospital stay is greater than one (1) day
- Subject must be fluent in English
Exclusion
- Age is younger than 55 years
- Subjects with a primary neurological or neurosurgical condition such as stroke, epilepsy, brain tumor, or witnessed seizures, Parkinson's disease, traumatic brain injury, or s/p craniectomy
- Active CNS substance abuse, intoxication, or withdrawal
- Unarousable or unresponsive subjects with RASS \<-3
- Subject is blind, deaf, or unable to speak or understand English
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06999967
Start Date
June 1 2025
End Date
May 30 2026
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Hospital and Clinics
Stanford, California, United States, 94305